Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
78.8M
-
Shares change
-
-3.81M
-
Total reported value, excl. options
-
$686M
-
Value change
-
-$218M
-
Put/Call ratio
-
1.05
-
Number of buys
-
107
-
Number of sells
-
-79
-
Price
-
$8.71
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q4 2024
233 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q4 2024.
Kura Oncology, Inc. - Common Stock (KURA) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.8M shares
of 87.5M outstanding shares and own 90.06% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.93M shares), ARMISTICE CAPITAL, LLC (5.8M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.08M shares), VANGUARD GROUP INC (4.82M shares), RA CAPITAL MANAGEMENT, L.P. (4.45M shares), EcoR1 Capital, LLC (3.56M shares), STATE STREET CORP (3.35M shares), MORGAN STANLEY (3.27M shares), BVF INC/IL (2.57M shares), and MILLENNIUM MANAGEMENT LLC (2.37M shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.